Literature DB >> 18635595

Dissecting the contribution of innate and antigen-specific pathways to the breach of self-tolerance observed in a murine model of arthritis.

M B Nickdel1, P Conigliaro, G Valesini, S Hutchison, R Benson, R V Bundick, A J Leishman, I B McInnes, J M Brewer, P Garside.   

Abstract

BACKGROUND: The relative roles of innate immunity and antigen-specific T cells in rheumatoid arthritis remain controversial. Previous studies demonstrated that T-helper type 1 cells of irrelevant antigen specificity (ovalbumin) induced a transient arthritis in BALB/c mice, which recapitulates many of the pre-articular and articular features of human disease and is associated with the emergence of autoreactive T and B-cell responses to joint-specific antigens. However, the mechanisms underlying this phenomenon were unclear.
OBJECTIVES: The aim of this study was to dissect the relative contribution of innate and heterologous antigen-specific pathways to the breach of self-tolerance and pathology observed in this model and how this may result from modified T and B-cell interactions.
METHODS: To address this issue, experimental arthritis was elicited either by a non-specific inflammatory stimulus alone, by activation of T cells of an irrelevant specificity or a combination of both.
RESULTS: The non-specific inflammatory response generated by lipopolysaccharide led to articular inflammation and cartilage erosion, but did not break tolerance to joint-specific antigens. In contrast, local activation of T cells of an irrelevant specificity produced a similar pathological picture but, in addition, induced T-cell responses to unrelated joint-specific antigens with associated activation of autoreactive B cells. These effects could be further potentiated by the addition of lipopolysaccharide.
CONCLUSION: These data demonstrate that non-specific inflammation alone is insufficient to breach self-tolerance. In contrast, T cells of an irrelevant specificity, when triggered locally in an antigen-specific manner, can breach self-tolerance leading to arthritis and autoantibody production, which can then be amplified in a non-specific manner.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18635595     DOI: 10.1136/ard.2008.089300

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN: 0003-4967            Impact factor:   19.103


  8 in total

1.  N-α-benzoyl-N5-(2-chloro-1-iminoethyl)-L-ornithine amide, a protein arginine deiminase inhibitor, reduces the severity of murine collagen-induced arthritis.

Authors:  Van C Willis; Alison M Gizinski; Nirmal K Banda; Corey P Causey; Bryan Knuckley; Kristen N Cordova; Yuan Luo; Brandt Levitt; Magdalena Glogowska; Piyanka Chandra; Liudmila Kulik; William H Robinson; William P Arend; Paul R Thompson; V Michael Holers
Journal:  J Immunol       Date:  2011-02-23       Impact factor: 5.422

2.  Hsp65-Producing Lactococcocus lactis Prevents Antigen-Induced Arthritis in Mice.

Authors:  Guilherme Gusmao-Silva; Sarah Leão Fiorini Aguiar; Mariana Camila Gonçalves Miranda; Mauro Andrade Guimarães; Juliana Lima Alves; Angélica Thomaz Vieira; Denise Carmona Cara; Anderson Miyoshi; Vasco Ariston Azevedo; Rafael Pires Oliveira; Ana Maria Caetano Faria
Journal:  Front Immunol       Date:  2020-09-23       Impact factor: 7.561

3.  In vivo two-photon imaging of T cell motility in joint-draining lymph nodes in a mouse model of rheumatoid arthritis.

Authors:  Tamás Kobezda; Sheida Ghassemi-Nejad; Tibor T Glant; Katalin Mikecz
Journal:  Cell Immunol       Date:  2012-09-05       Impact factor: 4.868

4.  TCRβ Sequencing Reveals Spatial and Temporal Evolution of Clonal CD4 T Cell Responses in a Breach of Tolerance Model of Inflammatory Arthritis.

Authors:  Shaima Al Khabouri; Robert A Benson; Catriona T Prendergast; Joshua I Gray; Thomas D Otto; James M Brewer; Paul Garside
Journal:  Front Immunol       Date:  2021-04-27       Impact factor: 7.561

5.  Local microbleeding facilitates IL-6- and IL-17-dependent arthritis in the absence of tissue antigen recognition by activated T cells.

Authors:  Masaaki Murakami; Yuko Okuyama; Hideki Ogura; Shogo Asano; Yasunobu Arima; Mineko Tsuruoka; Masaya Harada; Minoru Kanamoto; Yukihisa Sawa; Yoichiro Iwakura; Kiyoshi Takatsu; Daisuke Kamimura; Toshio Hirano
Journal:  J Exp Med       Date:  2011-01-10       Impact factor: 14.307

6.  A four-step model for the IL-6 amplifier, a regulator of chronic inflammations in tissue-specific MHC class II-associated autoimmune diseases.

Authors:  Masaaki Murakami; Toshio Hirano
Journal:  Front Immunol       Date:  2011-06-16       Impact factor: 7.561

7.  Combination with methotrexate and cyclophosphamide attenuated maturation of dendritic cells: inducing Treg skewing and Th17 suppression in vivo.

Authors:  Xiaoyang Yu; Caihong Wang; Jing Luo; Xiangcong Zhao; Lixing Wang; Xiaofeng Li
Journal:  Clin Dev Immunol       Date:  2013-09-30

8.  Serological markers associated with disease activity in patients with rheumatoid arthritis treated with rituximab.

Authors:  Paola Conigliaro; Paola Triggianese; Maria Sole Chimenti; Ramona Lucchetti; Barbara Kroegler; Roberto Perricone
Journal:  J Int Med Res       Date:  2016-09       Impact factor: 1.671

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.